Left atrial appendage closure in patients with atrial fibrillation: grey zones involving trials, meta-analysis, and decision-making
Abstract
This editorial refers to ‘Long-Term Efficacy and Safety of Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials, by P. Karakasis et al. , https://doi.org/10.1093/europace/ euag159 and ‘Comparative Evaluation of Left Atrial Appendage Occlusion And Oral Anticoagulation: A Bayesian Meta-Analysis of Randomized Controlled Trials’, by K. S. Athmakuri et al. , https://doi.org/10.1093/europace/euag163
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.